DE69634043D1 - Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie - Google Patents
Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapieInfo
- Publication number
- DE69634043D1 DE69634043D1 DE69634043T DE69634043T DE69634043D1 DE 69634043 D1 DE69634043 D1 DE 69634043D1 DE 69634043 T DE69634043 T DE 69634043T DE 69634043 T DE69634043 T DE 69634043T DE 69634043 D1 DE69634043 D1 DE 69634043D1
- Authority
- DE
- Germany
- Prior art keywords
- circular dna
- genetherapy
- manufacturing process
- dna molecular
- reaction treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factors [FGF]
- C07K14/501—Fibroblast growth factors [FGF] acidic FGF [aFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510825 | 1995-09-15 | ||
FR9510825A FR2738842B1 (fr) | 1995-09-15 | 1995-09-15 | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
PCT/FR1996/001414 WO1997010343A1 (fr) | 1995-09-15 | 1996-09-13 | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69634043D1 true DE69634043D1 (de) | 2005-01-20 |
DE69634043T2 DE69634043T2 (de) | 2005-08-18 |
Family
ID=9482580
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69634043T Expired - Lifetime DE69634043T2 (de) | 1995-09-15 | 1996-09-13 | Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie |
DE69636878T Expired - Lifetime DE69636878T2 (de) | 1995-09-15 | 1996-09-13 | Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie |
DE69638314T Expired - Lifetime DE69638314D1 (de) | 1995-09-15 | 1996-09-13 | Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69636878T Expired - Lifetime DE69636878T2 (de) | 1995-09-15 | 1996-09-13 | Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie |
DE69638314T Expired - Lifetime DE69638314D1 (de) | 1995-09-15 | 1996-09-13 | Zirkuläres DNA Molekül mit einem abhängigen Replikationsursprung, seine Herstellungsverfahren und seine Verwendung in der Gentherapie |
Country Status (20)
Country | Link |
---|---|
US (3) | US6977174B2 (de) |
EP (3) | EP0850310B1 (de) |
JP (3) | JP3818665B2 (de) |
KR (1) | KR100522369B1 (de) |
AT (3) | ATE352630T1 (de) |
BR (1) | BRPI9610511B8 (de) |
CA (1) | CA2229307C (de) |
CZ (1) | CZ294525B6 (de) |
DE (3) | DE69634043T2 (de) |
DK (3) | DK0850310T3 (de) |
ES (3) | ES2281721T3 (de) |
FR (1) | FR2738842B1 (de) |
HU (1) | HU224400B1 (de) |
IL (4) | IL123641A0 (de) |
NO (1) | NO323975B1 (de) |
PT (3) | PT1724354E (de) |
SK (1) | SK285317B6 (de) |
TW (1) | TWI231826B (de) |
WO (1) | WO1997010343A1 (de) |
ZA (1) | ZA967640B (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7038026B2 (en) * | 2000-05-26 | 2006-05-02 | Centelion | Purification of a triple heli formation with an immobilized oligonucleotide |
FR2738842B1 (fr) * | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
US7279313B2 (en) * | 1995-09-15 | 2007-10-09 | Centelion | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
US6156574A (en) | 1997-06-23 | 2000-12-05 | The Rockefeller University | Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof |
US6821759B1 (en) | 1997-06-23 | 2004-11-23 | The Rockefeller University | Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof |
HUP0004589A3 (en) | 1997-06-30 | 2003-08-28 | Centre Nat Rech Scient | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
US6022716A (en) * | 1998-04-10 | 2000-02-08 | Genset Sa | High throughput DNA sequencing vector |
AU5597200A (en) * | 1999-06-07 | 2000-12-28 | Cell Genesys, Inc. | Hybrid yeast-bacteria cloning system and uses thereof |
AU6229800A (en) * | 1999-07-20 | 2001-02-05 | Rockefeller University, The | Conditional homologous recombination of large genomic vector inserts |
FR2821855B1 (fr) † | 2001-03-09 | 2004-04-02 | Cayla | Genes synthetiques et plasmides bacteriens depourvus de cpg |
FR2822476B1 (fr) * | 2001-03-23 | 2004-04-02 | Aventis Pharma Sa | Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice |
AU2002325346A1 (en) | 2001-07-05 | 2003-01-21 | Aventis Pharma S.A. | Method of administration of a gene of interest to the heart and vasculature |
US7049121B2 (en) | 2001-12-20 | 2006-05-23 | Applied Molecular Evolution | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
US6989261B2 (en) * | 2001-12-20 | 2006-01-24 | Eli Lilly And Company | Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
FI116068B (fi) | 2003-09-15 | 2005-09-15 | Fit Biotech Oyj Plc | Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi |
JP4581851B2 (ja) * | 2004-07-27 | 2010-11-17 | セイコーエプソン株式会社 | 電気光学装置の駆動回路及び駆動方法、電気光学装置並びに電子機器 |
EP1882036B1 (de) * | 2005-05-17 | 2012-02-15 | Ozgene Pty Ltd | Sequentielles klonierungssystem |
US8716021B2 (en) * | 2005-09-07 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of replicators to prevent gene silencing |
US20090053295A1 (en) * | 2005-10-01 | 2009-02-26 | Charles Stout | Regulatable fusion promoters |
GB0606190D0 (en) | 2006-03-28 | 2006-05-10 | Isis Innovation | Construct |
EP2310500B1 (de) * | 2008-07-18 | 2015-03-11 | Maxcyte, Inc. | Verfahren zur optimierung einer elektroporation |
EP2221066A1 (de) | 2009-02-18 | 2010-08-25 | Sanofi-Aventis | Verwendung des VgII3-Aktivitätsmodulators zur Modulierung von Adipogenese |
ES2566553T3 (es) | 2010-03-17 | 2016-04-13 | Association Institut De Myologie | ARNnp U7 modificados para el tratamiento de las enfermedades neuromusculares |
WO2012069657A1 (en) | 2010-11-26 | 2012-05-31 | Institut Pasteur | Identification of a human gyrovirus and applications. |
WO2013083753A2 (en) | 2011-12-07 | 2013-06-13 | Institut Pasteur | Identification of a swine parecho-like virus and applications |
US9550998B2 (en) | 2012-08-29 | 2017-01-24 | Nature Technology Corporation | DNA plasmids with improved expression |
WO2014077863A1 (en) | 2012-11-19 | 2014-05-22 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
CA2902875A1 (en) * | 2013-03-14 | 2014-09-25 | Epeius Biotechnologies Corporation | Improved thymidine kinase gene |
EP3456821B2 (de) | 2017-09-19 | 2024-01-24 | Deutsches Krebsforschungszentrum | Nicht integrierende dna-vektoren zur genetischen modifikation von zellen |
WO2019057774A1 (en) | 2017-09-19 | 2019-03-28 | Deutsches Krebsforschungszentrum | NON-INTEGRATING DNA VECTORS FOR THE GENETIC MODIFICATION OF CELLS |
DK3768846T3 (da) | 2018-03-21 | 2023-07-24 | Aldevron L L C | Virale og ikke-virale nanoplasmidvektorer med forbedret produktion |
WO2023241567A1 (zh) * | 2022-06-13 | 2023-12-21 | 南京金斯瑞生物科技有限公司 | 一种可提高无筛选标签质粒制备效率的野生型-突变体π蛋白切换表达系统 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4190495A (en) * | 1976-09-27 | 1980-02-26 | Research Corporation | Modified microorganisms and method of preparing and using same |
US4342832A (en) * | 1979-07-05 | 1982-08-03 | Genentech, Inc. | Method of constructing a replicable cloning vehicle having quasi-synthetic genes |
US4727028A (en) * | 1981-06-22 | 1988-02-23 | Eli Lilly And Company | Recombinant DNA cloning vectors and the eukaryotic and prokaryotic transformants thereof |
US4654307A (en) * | 1983-02-17 | 1987-03-31 | The Research Foundation Of State University Of New York | Novel bacteria containing a plasmid having a tRNA code |
US4761367A (en) * | 1984-11-07 | 1988-08-02 | The University Of North Carolina At Chapel Hill | Vectors suitable for detection of eukaryotic DNA regulatory sequences |
US5859208A (en) * | 1988-07-06 | 1999-01-12 | Fiddes; John C. | Human basic fibroblast growth factor analog |
US5198343A (en) * | 1986-08-05 | 1993-03-30 | Transgene, S.A. | Method for expressing a heterologous protein in a dapD- mutant of E. coli and the strain obtained |
US5591632A (en) * | 1987-03-02 | 1997-01-07 | Beth Israel Hospital | Recombinant BCG |
US5510099A (en) * | 1987-05-01 | 1996-04-23 | Stratagene | Mutagenesis testing using transgenic non-human animals carrying test DNA sequences |
US5024939A (en) * | 1987-07-09 | 1991-06-18 | Genentech, Inc. | Transient expression system for producing recombinant protein |
US5693622A (en) * | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
EP0416505A3 (en) * | 1989-09-04 | 1991-10-02 | Takeda Chemical Industries, Ltd. | Expression plasmids and use thereof |
EP0485701A1 (de) * | 1990-09-28 | 1992-05-20 | American Cyanamid Company | Einfügen von DNS mittels abgewandelter Transposons |
TW201794B (de) * | 1991-05-03 | 1993-03-11 | American Cyanamid Co | |
US5714323A (en) * | 1991-08-30 | 1998-02-03 | The University Of Medecine And Dentistry Of New Jersey | Over expression of single-stranded molecules |
US5444149A (en) * | 1992-05-11 | 1995-08-22 | Duke University | Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation |
US5434065A (en) * | 1993-05-06 | 1995-07-18 | President And Fellows Of Harvard College | In vivo selection of microbial virulence genes |
ATE218893T1 (de) * | 1993-08-12 | 2002-06-15 | Neurotech Sa | Biokompatible immunoisolatorische kapseln, die genetisch veränderte zellen enthalten |
US5679647A (en) * | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
US5700657A (en) * | 1993-12-13 | 1997-12-23 | Genzyme Corporation | Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby |
IL109558A (en) * | 1994-05-04 | 2004-08-31 | Yissum Res Dev Co | DNA structures Derived from the SV40 virus that include DNA sequences External |
JPH10502535A (ja) * | 1994-07-08 | 1998-03-10 | シェーリング コーポレイション | c−fosプロモーター活性化タンパク質をコードする核酸を同定する方法 |
DE4428402A1 (de) * | 1994-08-11 | 1996-02-15 | Boehringer Mannheim Gmbh | Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen |
US5792647A (en) * | 1995-02-13 | 1998-08-11 | The Johns Hopkins University | Bacterial catabolism of chitin |
US6254874B1 (en) * | 1995-04-13 | 2001-07-03 | President And Fellows Of Harvard College | Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
US5763270A (en) * | 1995-06-07 | 1998-06-09 | Genemedicine, Inc. | Plasmid for delivery of nucleic acids to cells and methods of use |
US7279313B2 (en) * | 1995-09-15 | 2007-10-09 | Centelion | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
US7364894B2 (en) * | 1995-09-15 | 2008-04-29 | Centelion | Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
FR2738842B1 (fr) * | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
US5830879A (en) * | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
US5851808A (en) * | 1997-02-28 | 1998-12-22 | Baylor College Of Medicine | Rapid subcloning using site-specific recombination |
US5874259A (en) * | 1997-11-21 | 1999-02-23 | Wisconsin Alumni Research Foundation | Conditionally amplifiable BAC vector |
-
1995
- 1995-09-15 FR FR9510825A patent/FR2738842B1/fr not_active Expired - Lifetime
-
1996
- 1996-09-10 ZA ZA967640A patent/ZA967640B/xx unknown
- 1996-09-13 ES ES04016978T patent/ES2281721T3/es not_active Expired - Lifetime
- 1996-09-13 AT AT04016978T patent/ATE352630T1/de active
- 1996-09-13 JP JP51171697A patent/JP3818665B2/ja not_active Expired - Fee Related
- 1996-09-13 AT AT96931124T patent/ATE284966T1/de active
- 1996-09-13 EP EP96931124A patent/EP0850310B1/de not_active Expired - Lifetime
- 1996-09-13 ES ES96931124T patent/ES2233975T3/es not_active Expired - Lifetime
- 1996-09-13 IL IL12364196A patent/IL123641A0/xx active IP Right Grant
- 1996-09-13 EP EP06017245A patent/EP1724354B1/de not_active Expired - Lifetime
- 1996-09-13 PT PT06017245T patent/PT1724354E/pt unknown
- 1996-09-13 DK DK96931124T patent/DK0850310T3/da active
- 1996-09-13 PT PT96931124T patent/PT850310E/pt unknown
- 1996-09-13 PT PT04016978T patent/PT1508620E/pt unknown
- 1996-09-13 DE DE69634043T patent/DE69634043T2/de not_active Expired - Lifetime
- 1996-09-13 DK DK04016978T patent/DK1508620T3/da active
- 1996-09-13 AT AT06017245T patent/ATE492642T1/de active
- 1996-09-13 HU HU9900018A patent/HU224400B1/hu not_active IP Right Cessation
- 1996-09-13 DE DE69636878T patent/DE69636878T2/de not_active Expired - Lifetime
- 1996-09-13 ES ES06017245T patent/ES2357098T3/es not_active Expired - Lifetime
- 1996-09-13 WO PCT/FR1996/001414 patent/WO1997010343A1/fr active Application Filing
- 1996-09-13 BR BRPI9610511A patent/BRPI9610511B8/pt active IP Right Grant
- 1996-09-13 KR KR1019980701938A patent/KR100522369B1/ko not_active IP Right Cessation
- 1996-09-13 CA CA2229307A patent/CA2229307C/fr not_active Expired - Fee Related
- 1996-09-13 DK DK06017245.9T patent/DK1724354T3/da active
- 1996-09-13 US US09/043,193 patent/US6977174B2/en not_active Expired - Lifetime
- 1996-09-13 EP EP04016978A patent/EP1508620B1/de not_active Expired - Lifetime
- 1996-09-13 DE DE69638314T patent/DE69638314D1/de not_active Expired - Lifetime
- 1996-09-13 CZ CZ1998788A patent/CZ294525B6/cs not_active IP Right Cessation
- 1996-09-13 SK SK347-98A patent/SK285317B6/sk not_active IP Right Cessation
- 1996-09-14 TW TW090120803A patent/TWI231826B/zh not_active IP Right Cessation
-
1998
- 1998-03-10 NO NO19981044A patent/NO323975B1/no not_active IP Right Cessation
- 1998-03-11 IL IL123641A patent/IL123641A/en not_active IP Right Cessation
-
2005
- 2005-12-02 JP JP2005348779A patent/JP4585435B2/ja not_active Expired - Fee Related
-
2006
- 2006-01-26 IL IL173399A patent/IL173399A/en not_active IP Right Cessation
-
2007
- 2007-08-07 JP JP2007205143A patent/JP4756014B2/ja not_active Expired - Fee Related
- 2007-10-30 US US11/978,614 patent/US20090130674A1/en not_active Abandoned
-
2008
- 2008-05-27 US US12/153,881 patent/US20090149406A1/en not_active Abandoned
-
2010
- 2010-08-02 IL IL207348A patent/IL207348A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634043D1 (de) | Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie | |
WO1996021007A3 (en) | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells | |
PT830376E (pt) | Processo de producao de eritropoietina isenta de proteinas animais | |
NO911688L (no) | Neurotrophin-3, en ny neurotrofisk faktor relatert til neurovekstfaktor og hjerne-avledet neurotrofisk faktor. | |
PT93996A (pt) | Processo para a producao de factor de crescimento de celulas endoteliais vasculares e de dna codificador do mesmo | |
ATE188740T1 (de) | Viruspartikel mit veraendertem wirtspektrum | |
BR8107293A (pt) | Polipetidio anti-viral dna de duplo cordao veiculo de expressao plasmidico replicavel microorganismo transformado plasmidio processo de formacao do dito dna e do dito polipeptidio composicao farmaceutica e uso do dito polipeptidio | |
ATE159297T1 (de) | Expression von menschlichen serumalbumin in methylotrophischen hefen | |
AU8110487A (en) | DNA molecules coding for proteins targeted to plant cell walls | |
Nash | Purification of Bacteriophage λ, Int Protein | |
ATE222601T1 (de) | Methode zur expression in und isolation von biologisch aktiven molekülen aus urin | |
ES2070125T3 (es) | Factor de crecimiento fibroblastico acido mutante. | |
CA2037677A1 (en) | Process for production of exogenous gene or its product in plant cells | |
ES2078243T3 (es) | Mejoras en o relativas a la expresion eucariotica. | |
DK0629238T3 (da) | Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi | |
DE69331216T2 (de) | Planze resistent gegen mindestens zwei viren und dessen preparation | |
RU94043698A (ru) | СПОСОБ ПОЛУЧЕНИЯ ФЕРМЕНТА ДЕСТАБИЛАЗЫ, ОБЛАДАЮЩЕГО ФИБРИНОЛИТИЧЕСКОЙ, ТРОМБОЛИТИЧЕСКОЙ, ЭНДО- И ЭКЗО- Е( -glu)-Lys-ИЗОПЕПТИДАЗНОЙ И АМИДОЛИТИЧЕСКОЙ АКТИВНОСТЬЮ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: CENTELION, VITRY SUR SEINE, FR |
|
8364 | No opposition during term of opposition |